Group 1 - The company has signed a sales agreement with Guangfa Bank and Ping An Bank to sell its fund starting from August 11, 2025 [1][5] - The fund involved is the Invesco Great Wall CSI Hong Kong Stock Connect Innovative Drug ETF Linked Fund [1] - Investors can inquire about details through the company's customer service or the respective banks' websites [3] Group 2 - The company offers a regular investment plan where investors can set up automatic deductions for fund purchases [2] - If the banks open conversion services for the fund, investors must ensure the funds are in redeemable and purchasable states before proceeding [2] - The company may provide fee discounts for one-time or regular investment purchases, subject to the banks' arrangements [2] Group 3 - The company has issued a risk warning regarding the significant premium of its Nasdaq Technology Weighted ETF in the secondary market [5] - If the premium does not decrease effectively by August 11, 2025, the company may apply for temporary trading suspension to alert the market [5] - The fund's trading price is influenced by market supply and demand, systemic risks, and liquidity risks, which may lead to potential losses for investors [5][6]